Skip to main content
  News
FundaMental Pharma appoints Dr. Dirk Beher as Chief Executive Officer
April 11, 2024

FundaMental Pharma appoints Dr. Dirk Beher as Chief Executive Officer

Highly experienced biotech executive, with over a quarter of a century of CNS drug discovery experience Beher takes over the role of Chief Executive Officer…
FundaMental Pharma Appoints Industry Veteran Dr. Lorenz Mayr as Non-Executive Director
March 20, 2024

FundaMental Pharma Appoints Industry Veteran Dr. Lorenz Mayr as Non-Executive Director

Appointment underscores FundaMental’s ambition to develop medicines for neurodegenerative diseases based on a breakthrough molecular mechanism Heidelberg, GERMANY, 20 March 2024 - FundaMental Pharma GmbH,…
FundaMental Pharma launches with EUR 10 million in Seed financing led by BGV and Thuja Capital to advance a First-in-Class neuroprotectant
November 17, 2022

FundaMental Pharma launches with EUR 10 million in Seed financing led by BGV and Thuja Capital to advance a First-in-Class neuroprotectant

Heidelberg, Germany – 17 November 2022 – FundaMental Pharma GmbH (“FundaMental”), a preclinical neuroscience company spun out of Heidelberg University, today announces that it has launched…
Spacing rules in the brain: Novel compounds that act as molecular spacers in the brain prevent neurodegeneration
June 23, 2021

Spacing rules in the brain: Novel compounds that act as molecular spacers in the brain prevent neurodegeneration

High-Tech Gründerfonds (HTGF) provides seed funding for the neuro start-up FundaMental Pharma GmbH (FMP), a spin-off of the Interdisciplinary Center for Neuroscience (IZN) at Heidelberg…
A New Villain in Neuronal Death – A newly discovered partnership for glutamate triggers brain toxicity
October 9, 2020

A New Villain in Neuronal Death – A newly discovered partnership for glutamate triggers brain toxicity

Jones S A New Villain in Neuronal Death – A newly discovered partnership for glutamate triggers brain toxicity Science 370, eaay3302 , doi: 10.1126/science.abe2791. Abstract…
Coupling of NMDA receptors and TRPM4 guides discovery of unconventional neuroprotectants
October 9, 2020

Coupling of NMDA receptors and TRPM4 guides discovery of unconventional neuroprotectants

Yan J, Bengtson P, Buchthal B, Hagenston A, Bading H. Coupling of NMDA receptors and TRPM4 guides discovery of unconventional neuroprotectants. Science 370, eaay3302 ,…
New class of highly effective inhibitors protects against neurodegeneration
October 8, 2020

New class of highly effective inhibitors protects against neurodegeneration

Heidelberg neurobiologists decode central mechanism of degenerative processes in the brains of mouse models and develop new principle for therapeutic agents Neurobiologists at Heidelberg University…
FundaMental Pharma appoints Dr. Dirk Beher as Chief Executive Officer
April 11, 2024

FundaMental Pharma appoints Dr. Dirk Beher as Chief Executive Officer

Highly experienced biotech executive, with over a quarter of a century of CNS drug discovery experience Beher takes over the role of Chief Executive Officer…
FundaMental Pharma Appoints Industry Veteran Dr. Lorenz Mayr as Non-Executive Director
March 20, 2024

FundaMental Pharma Appoints Industry Veteran Dr. Lorenz Mayr as Non-Executive Director

Appointment underscores FundaMental’s ambition to develop medicines for neurodegenerative diseases based on a breakthrough molecular mechanism Heidelberg, GERMANY, 20 March 2024 - FundaMental Pharma GmbH,…
FundaMental Pharma launches with EUR 10 million in Seed financing led by BGV and Thuja Capital to advance a First-in-Class neuroprotectant
November 17, 2022

FundaMental Pharma launches with EUR 10 million in Seed financing led by BGV and Thuja Capital to advance a First-in-Class neuroprotectant

Heidelberg, Germany – 17 November 2022 – FundaMental Pharma GmbH (“FundaMental”), a preclinical neuroscience company spun out of Heidelberg University, today announces that it has launched…
Spacing rules in the brain: Novel compounds that act as molecular spacers in the brain prevent neurodegeneration
June 23, 2021

Spacing rules in the brain: Novel compounds that act as molecular spacers in the brain prevent neurodegeneration

High-Tech Gründerfonds (HTGF) provides seed funding for the neuro start-up FundaMental Pharma GmbH (FMP), a spin-off of the Interdisciplinary Center for Neuroscience (IZN) at Heidelberg…
New class of highly effective inhibitors protects against neurodegeneration
October 8, 2020

New class of highly effective inhibitors protects against neurodegeneration

Heidelberg neurobiologists decode central mechanism of degenerative processes in the brains of mouse models and develop new principle for therapeutic agents Neurobiologists at Heidelberg University…
A New Villain in Neuronal Death – A newly discovered partnership for glutamate triggers brain toxicity
October 9, 2020

A New Villain in Neuronal Death – A newly discovered partnership for glutamate triggers brain toxicity

Jones S A New Villain in Neuronal Death – A newly discovered partnership for glutamate triggers brain toxicity Science 370, eaay3302 , doi: 10.1126/science.abe2791. Abstract…
Coupling of NMDA receptors and TRPM4 guides discovery of unconventional neuroprotectants
October 9, 2020

Coupling of NMDA receptors and TRPM4 guides discovery of unconventional neuroprotectants

Yan J, Bengtson P, Buchthal B, Hagenston A, Bading H. Coupling of NMDA receptors and TRPM4 guides discovery of unconventional neuroprotectants. Science 370, eaay3302 ,…